Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning

American Journal of Kidney Diseases

Volumn 40, Issue 1, 2002, Pages 51-58

  Sánchez Fructuoso, Ana I ^a   Cano, Montserrat ^a   Arroyo, Miguel ^a   Fernández, Christina ^a   Prats, Dolores ^a   Barrientos, Alberto ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Chelation therapy; Ethylenediaminetetraacetate (EDTA); Lead hypertension; Lead toxicity; Nephrotoxicity

Indexed keywords

COMPLECAL; DRINKING WATER; EDETATE CALCIUM DISODIUM; LEAD; LEAD ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE LEVEL; BRAIN LEVEL; CHELATION THERAPY; CONTROLLED STUDY; DRUG EFFECT; KIDNEY FAILURE; LEAD BLOOD LEVEL; LEAD POISONING; LIVER LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; RAT; TISSUE LEVEL; URINE LEVEL;

EID: 0036283763     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.33913     Document Type: Article

References (38)

1. Blood lead levels - United States, 1991-1994
2. Lead poisoning: A disease for the next millennium
3. Chronic lead nephropathy
4. Chronic lead nephropathy: The diagnostic use of calcium EDTA and the association with gout
5. Detection and treatment of occupational lead nephropathy
6. The role of lead in gout nephropathy
7. Contribution of lead to hypertension with renal impairment
8. Impairment of renal function with increasing blood lead concentrations in the general population
9. Occult lead intoxication as a cause of hypertension and renal failure
10. Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy
11. The metabolism of C14-labeled ethylenediaminetetraacetic acid in the rat
12. The metabolism of C14-labeled ethylenediaminetetraacetic acid in human beings
13. Mobilization and redistribution of lead over the course of calcium disodium ethilendiamine tetracetate chelation therapy
14. The mechanism of mobilization of lead by ethylenediaminetetraacetate
15. The effects of chelating agents on the tissue distribution and excretion of lead
16. Effects of calcium sodium ethylenediaminetetraacetate on the kinetics of distribution and excretion of lead in the rat
17. Renal effects of repeated administration of calcium disodium ethylenediaminetetraacetate during excessive exposure to lead in rats
18. Ascorbic acid and EDTA treatment of lead toxicity in rats
19. Retention of lead in the rat
20. Combined therapeutic potential of meso-2, 3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats
21. Lead-induced inclusion bodies. Results of ethylenediaminetetraacetic acid treatment
22. Effect of chelate treatments on kidney, bone and brain lead levels of lead-exposed mice
23. Comparative mobilization of lead by chelating agents
24. Determinación analítica conjunta de plomo y cadmio en viales de Resistocell
25. Lead dosage and the role of the intranuclear inclusion body
26. Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney
27. The mechanism of mobilization of lead by ethylenediaminetetraacetate
28. The effects of chelating agents on the tissue distribution and excretion of lead
29. Localization of lead in the kidney and liver of rats treated in vivo with lead acetate: Ultrastructural studies on unstained sections
30. Mobilization of lead by calcium versenate and dimercaptosuccinate in the rat
31. Lead in bone, distribution of lead in the human skeleton
32. The lead content of bone in subjects without recognized past lead exposure and in patients with renal disease
33. Maternal bone lead contribution to blood lead during and after pregnancy
34. Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy
35. Modeling normal aging bone loss, with consideration of bone loss in osteoporosis
36. Lead poisoning secondary to hyperthyroidism: Report of two cases
37. Mobilization of lead from bone in end-stage renal failure patients with secondary hyperparathyroidism
38. Effects of weight loss and exercise on the distribution of lead and essential trace elements in rats with prior lead exposure